Form 8-K - Current report:
SEC Accession No. 0001144204-18-057664
Filing Date
2018-11-06
Accepted
2018-11-06 17:03:12
Documents
3
Period of Report
2018-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv506430_8k.htm 8-K 28224
2 EXHIBIT 99.1 tv506430_ex99-1.htm EX-99.1 310325
3 GRAPHIC image_001.jpg GRAPHIC 4389
  Complete submission text file 0001144204-18-057664.txt   346123
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 181163839
SIC: 2834 Pharmaceutical Preparations